Affiliation:
1. Department of Ultrasonography Peking University First Hospital Beijing China
2. Department of Pathology Peking University First Hospital Beijing China
Abstract
AbstractObjectiveThis retrospective study involving a large dataset of unilateral multifocal papillary thyroid carcinoma (UM‐PTC) sought to identify factors that predict central lymph node metastases (CLNM) in patients.MethodsWe identified a cohort of 158 patients who underwent cervical ultrasonography followed by UM‐PTC diagnosis based on postoperative pathology. The relationship between CLNM and UM‐PTC clinical ultrasound features was evaluated using univariate and multivariate analyses. Receiver operating characteristic (ROC) curve analysis was used to determine the ability of total tumor diameter (TTD) to predict CLNM.ResultsAmong the 158 UM‐PTC patients, the incidence of CLNM was 29.7% (47/158). Univariate and multivariate analyses revealed that a number of similarity of sonographic features (NSSF) ≥4 (odds ratio [OR] = 11.335, 95% confidence interval [CI]: 3.95–32.50, p = 0.000), microcalcifications (OR = 3.54, 95% CI: 1.30–9.70, p = 0.014), a TTD of ≥2 cm (OR = 4.48, 95% CI: 1.62–12.34, p = 0.004), number of nodules ≥3 (OR = 13.17, 95% CI: 3.24–53.52, p = 0.000), and Lateral cervical lymph node metastasis (LLNM) (OR = 5.57, 95% CI: 1.59–19.48, p = 0.007) were independently associated with CLNM in UM‐PTC. ROC curve analysis revealed that the TTD cut‐off of 1.795 cm had a sensitivity of 0.723 and a specificity of 0.676 for predicting CLNM.ConclusionsPatients with UM‐PTC are at high risk of CLNM. NSSF ≥4, microcalcifications, TTD of ≥2 cm, LLNM, and a number of nodules ≥3 were independently associated with CLNM. Our data show that ultrasound may guide surgical decisions in the treatment of UM‐PTC.
Reference36 articles.
1. Controversies, consensus, and collaboration in the use of i therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association;Tuttle R;Thyroid,2019
2. Therapeutic outcomes of patients with multifocal papillary thyroid microcarcinomas and larger tumors;Ng SC;Int J Endocrinol,2017
3. Significance of multifocality in papillary thyroid carcinoma;Feng J;Eur J Surg Oncol,2020
4. Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma;Wu X;Gland Surg,2020
5. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases;Yu X;Ann Surg,2011